 |
Find Information on New Technologies and Pending Patents?
TOPIC: Information on pending U.S. patents may be obtained in the patent databases only if the application has published internationally or in the U.S. as a Pre-grant publication.
Using Dialog NewsRoom (File 990), a comprehensive, global news source that covers the leading newspapers, business magazines and newswires from all regions of the world, and Gale Group Newsletter Database (File 636), which contains the fulltext of specialty industry newsletters, you will be able to find additional, late-breaking information on pending patents for new technologies, as well as the background on the companies pursuing the patents.
COMMAND SUMMARY
BEGIN 636,990 CURRENT2
SELECT PATENT?(1N)(PENDING? OR APPLIC?)
SELECT S1 AND PROVECTUS/CO
REMOVE DUPLICATES
TYPE S3/8/1-3 FROM EACH
TYPE S3/7/16
HOW TO...
1. BEGIN Files 636 and 990 to search two key business databases together. Use the CURRENT2 feature to restrict the search to this year plus two years back.
2. SELECT terms for the first concept. Use the proximity connector (1N) for words adjacent, within one intervening word, in any order. OR synonyms together and enclose in parentheses.
3. Combine Set 1 (S1) with the name of the company in which you are interested on the Company Name field (/CO).
4. REMOVE DUPLICATES (RD) when searching more than one database. |
?B636,990 CURRENT2
SYSTEM:OS - DIALOG OneSearch
File 636:Gale Group Newsletter DB(TM) 1987-2007/Nov 29
(c) 2007 The Gale Group
File 990:NewsRoom Current Jul 01-2007/Dec 04
(c) 2007 Dialog
>>>CURRENT2 started
Set Items Description
--- ----- -----------
?S PATENT?(1N)(PENDING? OR APPLIC?)
193945 PATENT?
155582 PENDING?
813385 APPLIC?
S1 30511 PATENT?(1N)(PENDING? OR APPLIC?)
?S S1 AND PROVECTUS/CO
30511 S1
212 PROVECTUS/CO
S2 58 S1 AND PROVECTUS/CO
?RD
S3 36 RD (unique items) |
5. TYPE a sampling of titles FROM EACH of the databases using Format 8,K, which gives titles, publication dates and descriptors, and Key Word in Context (KWIC [K]).
To select the appropriate record number, look at the range of records in the TYPE command (e.g., 3/8,K/16 (Item 2 from File 990)).
Note: Some records have been omitted from this display. |
?T S3/8,K/1-2 FROM EACH
3/8,K/1 (Item 1 from file: 636)
DIALOG(R)File 636: Gale Group Newsletter DB(TM)
(c) 2007 The Gale Group. All rights reserved.
06665118 Supplier Number: 169988863 (USE FORMAT 7 FOR
FULLTEXT)
Speak with other shareholders about: (OTC BB:PVCT) ,
(Nasdaq:CACH) , (OTC BB:SKNY) , (NYSE:BSX).
Oct 18 , 2007
Word Count: 2147
Publisher Name: M2 Communications Ltd.
Company Names: *Provectus Pharmaceuticals Inc.
Industry Names: BUSN (Business); INTL (Business,
international)
...Pharmaceuticals, Inc. (OTCBB: PVCT - News) announced today
it has received allowance of its U.S. patent application,
protecting diagnostic uses of a new class of radiochemical . . .
(....)
3/8,K/15 (Item 1 from file: 990)
DIALOG(R)File 990: NewsRoom Current
(c) 2007 Dialog. All rights reserved.
1491518394 17V70KYT
StockDiagnostics.com Reiterates Provectus
Pharmaceutical's OPS Ranking of "8"
Market News Publishing US
Tuesday , November 20, 2007
Word Count: 397
Company Names: ZAMAGE DIGITAL IMAGING INC; SPM GROUP
INC; PROVECTUS PHARMACEUTICAL INC; PROVECTUS
PHARMACEUTICALS INC; EPS BIO TECHNOLOGY CORP; OPS
Dialog Update Date: 20071120; 00:31:05 EST
Text:
...of public companies. Go to stockdiagnostics@baystreet.com for a
description of StockDiagnostics.com's patent-pending technical
applications, such as OPS, OPS Rankings, The EPS Syndrome and
more. Full details are...
3/8,K/16 (Item 2 from file: 990)
DIALOG(R)File 990: NewsRoom Current
(c) 2007 Dialog. All rights reserved.
1490004723 17V404ML
Provectus Receives Patent Allowance From U.S.
Patent Office
Obesity, Fitness & Wellness Week
Saturday , November 17, 2007
Word Count: 216
Company Names: ZAMAGE DIGITAL IMAGING INC; SPM GROUP INC;
PROVECTUS PHARMACEUTICAL INC; PROVECTUS PHARMACEUTICALS INC
Dialog Update Date: 20071109; 20:40:51 EST
Event Names: PATENTS AND TRADEMARKS; ECONOMIC DEVELOPMENT
Geographic Names: USA; AMERICAS; NORTH AMERICA
Industry Names: HEALTH CARE SERVICES; MEDICAL AND HEALTH
Journal Subject: Health & Wellness; Healthcare
Text:
...Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com)
has received allowance of its U.S. patent application,
protecting therapeutic agents based on a novel radio dense
analog of its lead therapeutic product PV-10, from the United
States Patent and Trademark Office (USPTO) (see also).
The pending patent covers therapeutic agents that are.... |
6. TYPE selected records in Format 7, which gives the Bibliographic Citation and the Text.
The TYPE command in the example requests record number 16, which is the second record from File 990. The searcher may also use the FROM command and the database number to select a record from a particular database. For example, the TYPE command could have read T S3/7/2 FROM 990 to display the same record.
Note: Part of this record is omitted from the display |
?t s3/7/16
3/7/16 (Item 2 from file: 990)
DIALOG(R)File 990: NewsRoom Current
(c) 2007 Dialog. All rights reserved.
1490004723 17V404ML
Provectus Receives Patent Allowance From U.S. Patent Office
Obesity, Fitness & Wellness Week , p 4192
Saturday , November 17, 2007
Word Count: 216
Text:
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com)
has received allowance of its U.S. patent application, protecting
therapeutic agents based on a novel radio dense analog of its lead
therapeutic product PV-10, from the United States Patent and Trademark
Office (USPTO) (see also).
The pending patent covers therapeutic agents that are used in
conjunction with radiation therapy to improve the efficiency and
specificity of radiation for oncology. The agents, called radio
sensitizers, are based on a novel molecule related to PV-10, the
Company's lead oncology product. "Like PV-10, these new agents are
not radioactive; instead....”
Dees continued: "We remain focused on the therapeutic uses of PV-10
as a stand-alone product category, but cannot ignore the large potential
value of these products for cancer markets worldwide....”
Copyright (c) 2007 Obesity, Fitness & Wellness Week via NewsRx.com |
RELATED HOW DO I...? SOLUTIONS
NEED HELP?
Contact the Dialog Knowledge Center
Within North America +1 800 3 DIALOG (334 2564)
Outside North America 00 800 33 DIALOG (33 34 2564)
Web Form www.dialog.com/contacts/webform
|
You are viewing the
Click below to view the
 |
